These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36699)

  • 1. Bone marrow transplantation.
    Storb R; Santos GW
    Transplant Proc; 1979 Mar; 11(1):1163-6. PubMed ID: 36699
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunologic problems in allogenic and autologous bone marrow transplantation].
    Schwenke H; Helbig W; Kubel M; Schultze W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(2):217-23. PubMed ID: 6208106
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation.
    Helg C; Chapuis B; Bolle JF; Morel P; Salomon D; Roux E; Antonioli V; Jeannet M; Leski M
    Transplantation; 1994 Dec; 58(12):1420-2. PubMed ID: 7809937
    [No Abstract]   [Full Text] [Related]  

  • 4. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of HLA in bone marrow transplantation].
    Harada M; Mori T; Matsuda T
    Rinsho Ketsueki; 1985 Dec; 26(12):1927-35. PubMed ID: 3914558
    [No Abstract]   [Full Text] [Related]  

  • 6. Hematopoietic stem cell transplantation: 40 years of continuous progress and evolution.
    Porta F; Locatelli F; Burgio GR
    Haematologica; 2008 Nov; 93(11):1607-10. PubMed ID: 18978297
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bone marrow transplantation in chronic myeloid leukemia].
    Hansz J
    Acta Haematol Pol; 1992; 23(2 Suppl 1):38-48. PubMed ID: 1488871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft-vs-leukemia following bone marrow transplantation: a model of immunotherapy in man.
    Butturini A; Bortin MM; Seeger RC; Gale RP
    Prog Clin Biol Res; 1987; 244():371-90. PubMed ID: 3310000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current status and issues in hematopoietic stem cell transplantation].
    Harada M
    Fukuoka Igaku Zasshi; 2007 Feb; 98(2):35-47. PubMed ID: 17396570
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of fetal-maternal tolerance in hematopoietic stem cell transplantation.
    Teshima T; Matsuoka K; Ichinohe T
    Arch Immunol Ther Exp (Warsz); 2006; 54(3):165-72. PubMed ID: 16652218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation (1958-1978) : conditioning and graft-versus-host disease, indications in aplasias and leukemias.
    Mathe G; Schwarzenberg L
    Pathol Biol (Paris); 1979 Jun; 27(6):337-43. PubMed ID: 159426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
    Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y
    Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunobiology of bone marrow transplantation.
    Dicke KA; Lotzova E; Spitzer G; McCredie KB
    Semin Hematol; 1978 Jul; 15(3):263-82. PubMed ID: 27865
    [No Abstract]   [Full Text] [Related]  

  • 14. Composite vascularized skin/bone transplantation models for bone marrow-based tolerance studies.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Siemionow M
    Ann Plast Surg; 2006 Mar; 56(3):295-300. PubMed ID: 16508361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The double barrier in bone marrow transplantation.
    van Bekkum DW
    Semin Hematol; 1974 Jul; 11(3):325-40. PubMed ID: 4151846
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful therapy of viral leukemia by transplantation of histocompatibly unmatched marrow.
    Meredith RF; Okunewick JP; Kuhnert PM; Brozovich BJ; Weaver EV
    Exp Hematol; 1978 Mar; 6(3):273-82. PubMed ID: 25780
    [No Abstract]   [Full Text] [Related]  

  • 18. Transplantation of marrow from donors other than genotypically HLA-identical siblings.
    de Gast GC; Verdonck LF; Dekker AW; Mudde GC
    Neth J Med; 1987 Aug; 31(1-2):77-82. PubMed ID: 3309695
    [No Abstract]   [Full Text] [Related]  

  • 19. Achieving alloengraftment without graft-versus-host disease: approaches using mixed allogeneic bone marrow transplantation.
    Sykes M; Sharabi Y; Sachs DH
    Bone Marrow Transplant; 1988 Sep; 3(5):379-86. PubMed ID: 3056545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.